<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2002-09-19" modified="2018-01-31" version="193">
<accession>Q9Y6Q9</accession>
<accession>A4LAZ5</accession>
<accession>Q0VF45</accession>
<accession>Q5JYD9</accession>
<accession>Q5JYE0</accession>
<accession>Q9BR49</accession>
<accession>Q9UPC9</accession>
<accession>Q9UPG4</accession>
<accession>Q9UPG7</accession>
<name>NCOA3_HUMAN</name>
<protein>
<recommendedName>
<fullName>Nuclear receptor coactivator 3</fullName>
<shortName>NCoA-3</shortName>
<ecNumber>2.3.1.48</ecNumber>
</recommendedName>
<alternativeName>
<fullName>ACTR</fullName>
</alternativeName>
<alternativeName>
<fullName>Amplified in breast cancer 1 protein</fullName>
<shortName>AIB-1</shortName>
</alternativeName>
<alternativeName>
<fullName>CBP-interacting protein</fullName>
<shortName>pCIP</shortName>
</alternativeName>
<alternativeName>
<fullName>Class E basic helix-loop-helix protein 42</fullName>
<shortName>bHLHe42</shortName>
</alternativeName>
<alternativeName>
<fullName>Receptor-associated coactivator 3</fullName>
<shortName>RAC-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Steroid receptor coactivator protein 3</fullName>
<shortName>SRC-3</shortName>
</alternativeName>
<alternativeName>
<fullName>Thyroid hormone receptor activator molecule 1</fullName>
<shortName>TRAM-1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">NCOA3</name>
<name type="synonym">AIB1</name>
<name type="synonym">BHLHE42</name>
<name type="synonym">RAC3</name>
<name type="synonym">TRAM1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27629" last="27634">
<title>TRAM-1, a novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1.</title>
<authorList>
<person name="Takeshita A."/>
<person name="Cardona G.R."/>
<person name="Koibuchi N."/>
<person name="Suen C.-S."/>
<person name="Chin W.W."/>
</authorList>
<dbReference type="PubMed" id="9346901"/>
<dbReference type="DOI" id="10.1074/jbc.272.44.27629"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>INTERACTION WITH CREBBP; PCAF; RARA; RXRA; THRA AND ESR</scope>
<source>
<tissue>Pituitary</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Cell" volume="90" first="569" last="580">
<title>Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300.</title>
<authorList>
<person name="Chen H."/>
<person name="Lin R.J."/>
<person name="Schiltz R.L."/>
<person name="Chakravarti D."/>
<person name="Nash A."/>
<person name="Nagy L."/>
<person name="Privalsky M.L."/>
<person name="Nakatani Y."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="9267036"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80516-4"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<scope>ENZYME ACTIVITY</scope>
<scope>VARIANT 1248-GLN--GLN-1250 DEL</scope>
<source>
<tissue>Leukemia</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="277" first="965" last="968">
<title>AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.</title>
<authorList>
<person name="Anzick S.L."/>
<person name="Kononen J."/>
<person name="Walker R.L."/>
<person name="Azorsa D.O."/>
<person name="Tanner M.M."/>
<person name="Guan X.-Y."/>
<person name="Sauter G."/>
<person name="Kallioniemi O.-P."/>
<person name="Trent J.M."/>
<person name="Meltzer P.S."/>
</authorList>
<dbReference type="PubMed" id="9252329"/>
<dbReference type="DOI" id="10.1126/science.277.5328.965"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>INTERACTION WITH ESR</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1997" name="Proc. Natl. Acad. Sci. U.S.A." volume="94" first="8479" last="8484">
<title>RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2.</title>
<authorList>
<person name="Li H."/>
<person name="Gomes P.J."/>
<person name="Chen J.D."/>
</authorList>
<dbReference type="PubMed" id="9238002"/>
<dbReference type="DOI" id="10.1073/pnas.94.16.8479"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>INTERACTION WITH VDR; RARA; PPARA; RXRA; THRA AND ESR</scope>
<scope>VARIANT 1248-GLN--GLN-1250 DEL</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2007-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS CYS-218; ILE-220; VAL-556; SER-559; HIS-586; ALA-777; LEU-1247 AND LYS-1247</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Nature" volume="414" first="865" last="871">
<title>The DNA sequence and comparative analysis of human chromosome 20.</title>
<authorList>
<person name="Deloukas P."/>
<person name="Matthews L.H."/>
<person name="Ashurst J.L."/>
<person name="Burton J."/>
<person name="Gilbert J.G.R."/>
<person name="Jones M."/>
<person name="Stavrides G."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beard L.M."/>
<person name="Beare D.M."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Brown A.J."/>
<person name="Buck D."/>
<person name="Burrill W.D."/>
<person name="Butler A.P."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clamp M."/>
<person name="Clark G."/>
<person name="Clark L.N."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V.E."/>
<person name="Collier R.E."/>
<person name="Connor R.E."/>
<person name="Corby N.R."/>
<person name="Coulson A."/>
<person name="Coville G.J."/>
<person name="Deadman R."/>
<person name="Dhami P.D."/>
<person name="Dunn M."/>
<person name="Ellington A.G."/>
<person name="Frankland J.A."/>
<person name="Fraser A."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Gwilliam R."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Heath P.D."/>
<person name="Ho S."/>
<person name="Holden J.L."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Jekosch K."/>
<person name="Johnson C.M."/>
<person name="Johnson D."/>
<person name="Kay M.P."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Lawlor S."/>
<person name="Lehvaeslaiho M.H."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J.D."/>
<person name="Marsh V.L."/>
<person name="Martin S.L."/>
<person name="McConnachie L.J."/>
<person name="McLay K."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mistry D."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Nickerson T."/>
<person name="Oliver K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce T.A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Prathalingam S.R."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Sycamore N."/>
<person name="Taylor R."/>
<person name="Tee L."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A.C."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whitehead S.L."/>
<person name="Whittaker P."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Hubbard T."/>
<person name="Durbin R.M."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
</authorList>
<dbReference type="PubMed" id="11780052"/>
<dbReference type="DOI" id="10.1038/414865a"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5)</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="Clin. Genet." volume="54" first="102" last="103">
<title>Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene).</title>
<authorList>
<person name="Shirazi S.K."/>
<person name="Bober M.A."/>
<person name="Coetzee G.A."/>
</authorList>
<dbReference type="PubMed" id="9727751"/>
</citation>
<scope>POLYMORPHISM OF POLY-GLN REGION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Cell" volume="98" first="675" last="686">
<title>Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase.</title>
<authorList>
<person name="Chen H."/>
<person name="Lin R.J."/>
<person name="Xie W."/>
<person name="Wilpitz D."/>
<person name="Evans R.M."/>
</authorList>
<dbReference type="PubMed" id="10490106"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80054-9"/>
</citation>
<scope>ACETYLATION AT LYS-616; LYS-619 AND LYS-620 BY CREBBP</scope>
<scope>MUTAGENESIS OF LYS-616; 619-LYS-LYS-620; LYS-647; LYS-681; LYS-687; LYS-700 AND LYS-708</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="FEBS Lett." volume="485" first="195" last="199">
<title>RAC-3 is a NF-kappa B coactivator.</title>
<authorList>
<person name="Werbajh S."/>
<person name="Nojek I."/>
<person name="Lanz R."/>
<person name="Costas M.A."/>
</authorList>
<dbReference type="PubMed" id="11094166"/>
<dbReference type="DOI" id="10.1016/S0014-5793(00)02223-7"/>
</citation>
<scope>INTERACTION WITH NFKB1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="1341" last="1352">
<title>A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.</title>
<authorList>
<person name="Watanabe M."/>
<person name="Yanagisawa J."/>
<person name="Kitagawa H."/>
<person name="Takeyama K."/>
<person name="Ogawa S."/>
<person name="Arao Y."/>
<person name="Suzawa M."/>
<person name="Kobayashi Y."/>
<person name="Yano T."/>
<person name="Yoshikawa H."/>
<person name="Masuhiro Y."/>
<person name="Kato S."/>
</authorList>
<dbReference type="PubMed" id="11250900"/>
<dbReference type="DOI" id="10.1093/emboj/20.6.1341"/>
</citation>
<scope>INTERACTION WITH DDX5</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="3549" last="3561">
<title>Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) coactivator activity by I kappa B kinase.</title>
<authorList>
<person name="Wu R.-C."/>
<person name="Qin J."/>
<person name="Hashimoto Y."/>
<person name="Wong J."/>
<person name="Xu J."/>
<person name="Tsai S.Y."/>
<person name="Tsai M.-J."/>
<person name="O'Malley B.W."/>
</authorList>
<dbReference type="PubMed" id="11971985"/>
<dbReference type="DOI" id="10.1128/MCB.22.10.3549-3561.2002"/>
</citation>
<scope>SUBUNIT OF A COMPLEX CONTAINING CREBBP; NCOA2; IKKA; IKKB AND IKBKG</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="6210" last="6220">
<title>BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation.</title>
<authorList>
<person name="Hsiao P.W."/>
<person name="Fryer C.J."/>
<person name="Trotter K.W."/>
<person name="Wang W."/>
<person name="Archer T.K."/>
</authorList>
<dbReference type="PubMed" id="12917342"/>
<dbReference type="DOI" id="10.1128/MCB.23.17.6210-6220.2003"/>
</citation>
<scope>INTERACTION WITH NR3C1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="7091" last="7097">
<title>Histone acetyltransferase-dependent chromatin remodeling and the vascular clock.</title>
<authorList>
<person name="Curtis A.M."/>
<person name="Seo S.B."/>
<person name="Westgate E.J."/>
<person name="Rudic R.D."/>
<person name="Smyth E.M."/>
<person name="Chakravarti D."/>
<person name="FitzGerald G.A."/>
<person name="McNamara P."/>
</authorList>
<dbReference type="PubMed" id="14645221"/>
<dbReference type="DOI" id="10.1074/jbc.M311973200"/>
</citation>
<scope>INTERACTION WITH NPAS2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2004" name="J. Steroid Biochem. Mol. Biol." volume="92" first="357" last="363">
<title>FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.</title>
<authorList>
<person name="Kino T."/>
<person name="Ichijo T."/>
<person name="Chrousos G.P."/>
</authorList>
<dbReference type="PubMed" id="15698540"/>
<dbReference type="DOI" id="10.1016/j.jsbmb.2004.09.003"/>
</citation>
<scope>INTERACTION WITH CASP8AP2</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="8439" last="8447">
<title>Male germ cell-associated kinase, a male-specific kinase regulated by androgen, is a coactivator of androgen receptor in prostate cancer cells.</title>
<authorList>
<person name="Ma A.H."/>
<person name="Xia L."/>
<person name="Desai S.J."/>
<person name="Boucher D.L."/>
<person name="Guan Y."/>
<person name="Shih H.M."/>
<person name="Shi X.B."/>
<person name="deVere White R.W."/>
<person name="Chen H.W."/>
<person name="Tepper C.G."/>
<person name="Kung H.J."/>
</authorList>
<dbReference type="PubMed" id="16951154"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-1636"/>
</citation>
<scope>SUBUNIT</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="EMBO J." volume="25" first="4223" last="4233">
<title>The catalytic subunit of the proteasome is engaged in the entire process of estrogen receptor-regulated transcription.</title>
<authorList>
<person name="Zhang H."/>
<person name="Sun L."/>
<person name="Liang J."/>
<person name="Yu W."/>
<person name="Zhang Y."/>
<person name="Wang Y."/>
<person name="Chen Y."/>
<person name="Li R."/>
<person name="Sun X."/>
<person name="Shang Y."/>
</authorList>
<dbReference type="PubMed" id="16957778"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7601306"/>
</citation>
<scope>INTERACTION WITH PSMB9</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-857 AND SER-867</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="Proc. Natl. Acad. Sci. U.S.A." volume="104" first="18067" last="18072">
<title>ANCCA, an estrogen-regulated AAA+ ATPase coactivator for ERalpha, is required for coregulator occupancy and chromatin modification.</title>
<authorList>
<person name="Zou J.X."/>
<person name="Revenko A.S."/>
<person name="Li L.B."/>
<person name="Gemo A.T."/>
<person name="Chen H.-W."/>
</authorList>
<dbReference type="PubMed" id="17998543"/>
<dbReference type="DOI" id="10.1073/pnas.0705814104"/>
</citation>
<scope>INTERACTION WITH ATAD2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214; SER-551; SER-728 AND SER-857</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="3110" last="3123">
<title>CK1delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions.</title>
<authorList>
<person name="Giamas G."/>
<person name="Castellano L."/>
<person name="Feng Q."/>
<person name="Knippschild U."/>
<person name="Jacob J."/>
<person name="Thomas R.S."/>
<person name="Coombes R.C."/>
<person name="Smith C.L."/>
<person name="Jiao L.R."/>
<person name="Stebbing J."/>
</authorList>
<dbReference type="PubMed" id="19339517"/>
<dbReference type="DOI" id="10.1093/nar/gkp136"/>
</citation>
<scope>PHOSPHORYLATION AT SER-601 BY CSNK1D/CK1</scope>
<scope>INTERACTION WITH CSNK1D</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-857</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-687</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214; SER-857 AND SER-867</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214; SER-551; SER-694; SER-728; SER-857; SER-1033 AND SER-1330</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-551</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-1171; ARG-1177 AND ARG-1188</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<comment type="function">
<text>Nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in a hormone-dependent fashion. Plays a central role in creating a multisubunit coactivator complex, which probably acts via remodeling of chromatin. Involved in the coactivation of different nuclear receptors, such as for steroids (GR and ER), retinoids (RARs and RXRs), thyroid hormone (TRs), vitamin D3 (VDR) and prostanoids (PPARs). Displays histone acetyltransferase activity. Also involved in the coactivation of the NF-kappa-B pathway via its interaction with the NFKB1 subunit.</text>
</comment>
<comment type="catalytic activity">
<text evidence="30">Acetyl-CoA + [protein]-L-lysine = CoA + [protein]-N(6)-acetyl-L-lysine.</text>
</comment>
<comment type="enzyme regulation">
<text>Coactivator activity on nuclear receptors and NF-kappa-B pathways is enhanced by various hormones, and the TNF cytokine, respectively. TNF stimulation probably enhances phosphorylation, which in turn activates coactivator function. In contrast, acetylation by CREBBP apparently suppresses coactivation of target genes by disrupting its association with nuclear receptors. Binds to CSNK1D.</text>
</comment>
<comment type="subunit">
<text evidence="13 14 18 19 20 21 22 23 24 25 26 27 28 29 31">Interacts with CARM1 (By similarity). Present in a complex containing NCOA2, IKKA, IKKB, IKBKG and the histone acetyltransferase protein CREBBP. Interacts with CASP8AP2, NR3C1 and PCAF. Interacts with ATAD2 and this interaction is enhanced by estradiol. Found in a complex containing NCOA3, AR and MAK. Interacts with DDX5. Interacts with PSMB9. Interacts with NPAS2. Interacts with NR4A3 (By similarity). Interacts with ESRRB; mediates the interaction between ESRRB and RNA polymerase II complexes and allows NCOA3 corecruitment to ESRRB, KLF4, NANOG, and SOX2 enhancer regions to trigger ESRRB-dependent gene activation involved in self-renewal and pluripotency (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-6598454">
<id>Q6PL18</id>
<label>ATAD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-2339854">
<id>Q86X55</id>
<label>CARM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>13</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-746012">
<id>Q92841</id>
<label>DDX17</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-447295">
<id>Q09472</id>
<label>EP300</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-81266">
<id>O14920</id>
<label>IKBKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-15626132">
<id>Q8VIM5-1</id>
<label>Myocd</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-603300">
<id>P28065</id>
<label>PSMB9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-355546">
<id>P61289</id>
<label>PSME3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-696162">
<id>P60484</id>
<label>PTEN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-413374">
<id>P10276</id>
<label>RARA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-743549">
<id>O43791</id>
<label>SPOP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-81196"/>
<interactant intactId="EBI-346797">
<id>P48281</id>
<label>Vdr</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<text>Mainly cytoplasmic and weakly nuclear. Upon TNF activation and subsequent phosphorylation, it translocates from the cytoplasm to the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y6Q9-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y6Q9-2</id>
<name>2</name>
<sequence type="described" ref="VSP_003407"/>
</isoform>
<isoform>
<id>Q9Y6Q9-3</id>
<name>3</name>
<sequence type="described" ref="VSP_003405 VSP_003407 VSP_003408"/>
</isoform>
<isoform>
<id>Q9Y6Q9-4</id>
<name>4</name>
<sequence type="described" ref="VSP_003405 VSP_003406 VSP_003407 VSP_003408"/>
</isoform>
<isoform>
<id>Q9Y6Q9-5</id>
<name>5</name>
<sequence type="described" ref="VSP_003408"/>
</isoform>
<text>Additional isoforms seem to exist.</text>
</comment>
<comment type="tissue specificity">
<text>Widely expressed. High expression in heart, skeletal muscle, pancreas and placenta. Low expression in brain, and very low in lung, liver and kidney.</text>
</comment>
<comment type="domain">
<text>Contains three Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. Motifs 1 and 2 are essential for the association with nuclear receptors, and constitute the RID domain (Receptor-interacting domain).</text>
</comment>
<comment type="PTM">
<text evidence="17">Acetylated by CREBBP. Acetylation occurs in the RID domain, and disrupts the interaction with nuclear receptors and regulates its function.</text>
</comment>
<comment type="PTM">
<text evidence="13">Methylated by CARM1.</text>
</comment>
<comment type="PTM">
<text evidence="20 27">Phosphorylated by IKK complex. Regulated its function. Phosphorylation at Ser-601 by CK1 promotes coactivator function.</text>
</comment>
<comment type="polymorphism">
<text evidence="32">The length of the poly-Gln region is polymorphic in the normal population.</text>
</comment>
<comment type="miscellaneous">
<text>NCOA3 is frequently amplified or overexpressed in breast and ovarian cancers.</text>
</comment>
<comment type="similarity">
<text evidence="39">Belongs to the SRC/p160 nuclear receptor coactivator family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/NCOA3ID505ch20q13.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/ncoa3/"/>
</comment>
<dbReference type="EC" id="2.3.1.48"/>
<dbReference type="EMBL" id="AF016031">
<property type="protein sequence ID" value="AAC51849.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF036892">
<property type="protein sequence ID" value="AAB92368.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF012108">
<property type="protein sequence ID" value="AAC51677.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF010227">
<property type="protein sequence ID" value="AAC51663.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF488684">
<property type="protein sequence ID" value="ABO43042.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL034418">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW75698.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471077">
<property type="protein sequence ID" value="EAW75702.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC119001">
<property type="protein sequence ID" value="AAI19002.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13406.1">
<molecule id="Q9Y6Q9-5"/>
</dbReference>
<dbReference type="CCDS" id="CCDS13407.1">
<molecule id="Q9Y6Q9-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS54472.1">
<molecule id="Q9Y6Q9-3"/>
</dbReference>
<dbReference type="PIR" id="T03851">
<property type="entry name" value="T03851"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001167559.1">
<molecule id="Q9Y6Q9-3"/>
<property type="nucleotide sequence ID" value="NM_001174088.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006525.2">
<molecule id="Q9Y6Q9-5"/>
<property type="nucleotide sequence ID" value="NM_006534.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_858045.1">
<molecule id="Q9Y6Q9-1"/>
<property type="nucleotide sequence ID" value="NM_181659.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.592142"/>
<dbReference type="PDB" id="1KBH">
<property type="method" value="NMR"/>
<property type="chains" value="A=1045-1091"/>
</dbReference>
<dbReference type="PDB" id="3L3X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.55"/>
<property type="chains" value="B=618-629"/>
</dbReference>
<dbReference type="PDB" id="3L3Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="B=735-746"/>
</dbReference>
<dbReference type="PDBsum" id="1KBH"/>
<dbReference type="PDBsum" id="3L3X"/>
<dbReference type="PDBsum" id="3L3Z"/>
<dbReference type="DisProt" id="DP00343"/>
<dbReference type="ProteinModelPortal" id="Q9Y6Q9"/>
<dbReference type="SMR" id="Q9Y6Q9"/>
<dbReference type="BioGrid" id="113841">
<property type="interactions" value="110"/>
</dbReference>
<dbReference type="CORUM" id="Q9Y6Q9"/>
<dbReference type="DIP" id="DIP-30876N"/>
<dbReference type="ELM" id="Q9Y6Q9"/>
<dbReference type="IntAct" id="Q9Y6Q9">
<property type="interactions" value="55"/>
</dbReference>
<dbReference type="MINT" id="MINT-231818"/>
<dbReference type="STRING" id="9606.ENSP00000361066"/>
<dbReference type="BindingDB" id="Q9Y6Q9"/>
<dbReference type="ChEMBL" id="CHEMBL1615382"/>
<dbReference type="iPTMnet" id="Q9Y6Q9"/>
<dbReference type="PhosphoSitePlus" id="Q9Y6Q9"/>
<dbReference type="SwissPalm" id="Q9Y6Q9"/>
<dbReference type="BioMuta" id="NCOA3"/>
<dbReference type="DMDM" id="23396777"/>
<dbReference type="EPD" id="Q9Y6Q9"/>
<dbReference type="PaxDb" id="Q9Y6Q9"/>
<dbReference type="PeptideAtlas" id="Q9Y6Q9"/>
<dbReference type="PRIDE" id="Q9Y6Q9"/>
<dbReference type="Ensembl" id="ENST00000371997">
<molecule id="Q9Y6Q9-3"/>
<property type="protein sequence ID" value="ENSP00000361065"/>
<property type="gene ID" value="ENSG00000124151"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000371998">
<molecule id="Q9Y6Q9-1"/>
<property type="protein sequence ID" value="ENSP00000361066"/>
<property type="gene ID" value="ENSG00000124151"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000372004">
<molecule id="Q9Y6Q9-5"/>
<property type="protein sequence ID" value="ENSP00000361073"/>
<property type="gene ID" value="ENSG00000124151"/>
</dbReference>
<dbReference type="GeneID" id="8202"/>
<dbReference type="KEGG" id="hsa:8202"/>
<dbReference type="UCSC" id="uc002xtk.4">
<molecule id="Q9Y6Q9-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8202"/>
<dbReference type="DisGeNET" id="8202"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000124151.18"/>
<dbReference type="GeneCards" id="NCOA3"/>
<dbReference type="HGNC" id="HGNC:7670">
<property type="gene designation" value="NCOA3"/>
</dbReference>
<dbReference type="HPA" id="CAB009800"/>
<dbReference type="HPA" id="HPA024210"/>
<dbReference type="MIM" id="601937">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y6Q9"/>
<dbReference type="OpenTargets" id="ENSG00000124151"/>
<dbReference type="PharmGKB" id="PA31472"/>
<dbReference type="eggNOG" id="ENOG410IQ5R">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410ZDZC">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000063109"/>
<dbReference type="HOVERGEN" id="HBG052583"/>
<dbReference type="InParanoid" id="Q9Y6Q9"/>
<dbReference type="KO" id="K11256"/>
<dbReference type="OMA" id="MQCFALS"/>
<dbReference type="OrthoDB" id="EOG091G152H"/>
<dbReference type="PhylomeDB" id="Q9Y6Q9"/>
<dbReference type="TreeFam" id="TF332652"/>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381340">
<property type="pathway name" value="Transcriptional regulation of white adipocyte differentiation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5687128">
<property type="pathway name" value="MAPK6/MAPK4 signaling"/>
</dbReference>
<dbReference type="SignaLink" id="Q9Y6Q9"/>
<dbReference type="SIGNOR" id="Q9Y6Q9"/>
<dbReference type="ChiTaRS" id="NCOA3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q9Y6Q9"/>
<dbReference type="GeneWiki" id="Nuclear_receptor_coactivator_3"/>
<dbReference type="GenomeRNAi" id="8202"/>
<dbReference type="PRO" id="PR:Q9Y6Q9"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 20"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000124151"/>
<dbReference type="CleanEx" id="HS_NCOA3"/>
<dbReference type="CleanEx" id="HS_RAC3"/>
<dbReference type="CleanEx" id="HS_TRAM1"/>
<dbReference type="Genevisible" id="Q9Y6Q9">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043234">
<property type="term" value="C:protein complex"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0050681">
<property type="term" value="F:androgen receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097718">
<property type="term" value="F:disordered domain specific binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004402">
<property type="term" value="F:histone acetyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016922">
<property type="term" value="F:ligand-dependent nuclear receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030374">
<property type="term" value="F:ligand-dependent nuclear receptor transcription coactivator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0035257">
<property type="term" value="F:nuclear hormone receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0047485">
<property type="term" value="F:protein N-terminus binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000993">
<property type="term" value="F:RNA polymerase II core binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046966">
<property type="term" value="F:thyroid hormone receptor binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043697">
<property type="term" value="P:cell dedifferentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071392">
<property type="term" value="P:cellular response to estradiol stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032870">
<property type="term" value="P:cellular response to hormone stimulus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030522">
<property type="term" value="P:intracellular receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045618">
<property type="term" value="P:positive regulation of keratinocyte differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902459">
<property type="term" value="P:positive regulation of stem cell population maintenance"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035624">
<property type="term" value="P:receptor transactivation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001141">
<property type="term" value="P:regulation of RNA biosynthetic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000035">
<property type="term" value="P:regulation of stem cell division"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd00083">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="CDD" id="cd00130">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="1.10.287.1070">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.130.10.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="4.10.280.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011598">
<property type="entry name" value="bHLH_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR010011">
<property type="entry name" value="DUF1518"/>
</dbReference>
<dbReference type="InterPro" id="IPR032565">
<property type="entry name" value="DUF4927"/>
</dbReference>
<dbReference type="InterPro" id="IPR036638">
<property type="entry name" value="HLH_DNA-bd_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR028818">
<property type="entry name" value="NCOA3"/>
</dbReference>
<dbReference type="InterPro" id="IPR009110">
<property type="entry name" value="Nuc_rcpt_coact"/>
</dbReference>
<dbReference type="InterPro" id="IPR014920">
<property type="entry name" value="Nuc_rcpt_coact_Ncoa-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR037077">
<property type="entry name" value="Nuc_rcpt_coact_Ncoa_int_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR017426">
<property type="entry name" value="Nuclear_rcpt_coactivator"/>
</dbReference>
<dbReference type="InterPro" id="IPR000014">
<property type="entry name" value="PAS"/>
</dbReference>
<dbReference type="InterPro" id="IPR035965">
<property type="entry name" value="PAS-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013767">
<property type="entry name" value="PAS_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR014935">
<property type="entry name" value="SRC/p160_LXXLL"/>
</dbReference>
<dbReference type="InterPro" id="IPR015943">
<property type="entry name" value="WD40/YVTN_repeat-like_dom_sf"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10684">
<property type="entry name" value="PTHR10684"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10684:SF3">
<property type="entry name" value="PTHR10684:SF3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07469">
<property type="entry name" value="DUF1518"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF16279">
<property type="entry name" value="DUF4927"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08815">
<property type="entry name" value="Nuc_rec_co-act"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00989">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08832">
<property type="entry name" value="SRC-1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF038181">
<property type="entry name" value="Nuclear_receptor_coactivator"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01151">
<property type="entry name" value="DUF1518"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00353">
<property type="entry name" value="HLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00091">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47459">
<property type="entry name" value="SSF47459"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55785">
<property type="entry name" value="SSF55785"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF69125">
<property type="entry name" value="SSF69125"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50888">
<property type="entry name" value="BHLH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50112">
<property type="entry name" value="PAS"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0012">Acyltransferase</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="initiator methionine" description="Removed" evidence="9">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Nuclear receptor coactivator 3" id="PRO_0000094406">
<location>
<begin position="2"/>
<end position="1424"/>
</location>
</feature>
<feature type="domain" description="bHLH" evidence="16">
<location>
<begin position="25"/>
<end position="82"/>
</location>
</feature>
<feature type="domain" description="PAS" evidence="15">
<location>
<begin position="110"/>
<end position="180"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with CREBBP" evidence="31">
<location>
<begin position="1023"/>
<end position="1093"/>
</location>
</feature>
<feature type="region of interest" description="Acetyltransferase">
<location>
<begin position="1097"/>
<end position="1304"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 1">
<location>
<begin position="685"/>
<end position="689"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 2">
<location>
<begin position="738"/>
<end position="742"/>
</location>
</feature>
<feature type="short sequence motif" description="LXXLL motif 3">
<location>
<begin position="1057"/>
<end position="1061"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="505"/>
<end position="671"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="976"/>
<end position="980"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gln">
<location>
<begin position="1248"/>
<end position="1278"/>
</location>
</feature>
<feature type="compositionally biased region" description="Met-rich">
<location>
<begin position="1392"/>
<end position="1417"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="9">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 8 10">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10 12">
<location>
<position position="551"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="569"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CK1" evidence="27">
<location>
<position position="601"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by CREBBP" evidence="17">
<location>
<position position="616"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by CREBBP" evidence="17">
<location>
<position position="619"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by CREBBP" evidence="17">
<location>
<position position="620"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="6">
<location>
<position position="687"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="694"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 10">
<location>
<position position="728"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 7 8 10">
<location>
<position position="857"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="860"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 8">
<location>
<position position="867"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1033"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="11">
<location>
<position position="1171"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="11">
<location>
<position position="1177"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine" evidence="11">
<location>
<position position="1188"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="1330"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3 and isoform 4." id="VSP_003405" evidence="37">
<original>E</original>
<variation>EVTSDGIFSPT</variation>
<location>
<position position="321"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_003406" evidence="37">
<location>
<begin position="837"/>
<end position="901"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 3 and isoform 4." id="VSP_003407" evidence="37 38">
<location>
<begin position="903"/>
<end position="917"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3, isoform 4 and isoform 5." id="VSP_003408" evidence="34 35 36 37">
<location>
<begin position="1214"/>
<end position="1217"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6094752." id="VAR_053527" evidence="33">
<original>R</original>
<variation>C</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs72645252." id="VAR_060695" evidence="33">
<original>R</original>
<variation>I</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6094756." id="VAR_053528">
<original>L</original>
<variation>F</variation>
<location>
<position position="369"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1052765." id="VAR_013831">
<original>G</original>
<variation>R</variation>
<location>
<position position="460"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs72645272." id="VAR_060696" evidence="33">
<original>I</original>
<variation>V</variation>
<location>
<position position="556"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230781." id="VAR_013832" evidence="33">
<original>P</original>
<variation>S</variation>
<location>
<position position="559"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230782." id="VAR_013833" evidence="33">
<original>Q</original>
<variation>H</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2230783." id="VAR_053529" evidence="33">
<original>S</original>
<variation>A</variation>
<location>
<position position="777"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs72645299." id="VAR_060697" evidence="33">
<original>M</original>
<variation>K</variation>
<location>
<position position="1247"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs72645298." id="VAR_060698" evidence="33">
<original>M</original>
<variation>L</variation>
<location>
<position position="1247"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_013834" evidence="28 30">
<location>
<begin position="1248"/>
<end position="1250"/>
</location>
</feature>
<feature type="mutagenesis site" description="Strongly reduces acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="616"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes acetylation by CREBBP." evidence="17">
<original>KK</original>
<variation>QQ</variation>
<location>
<begin position="619"/>
<end position="620"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="647"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="700"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect acetylation by CREBBP." evidence="17">
<original>K</original>
<variation>Q</variation>
<location>
<position position="708"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAC51663." ref="4" evidence="39">
<original>DG</original>
<variation>EA</variation>
<location>
<begin position="131"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="619"/>
<end position="626"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="736"/>
<end position="743"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1049"/>
<end position="1060"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1069"/>
<end position="1075"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1078"/>
<end position="1084"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="1086"/>
<end position="1088"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1KBH"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3L3X"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3L3Z"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250"/>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O09000"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00140"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00981"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10490106"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11094166"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11250900"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11971985"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12917342"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14645221"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15698540"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16951154"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16957778"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17998543"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19339517"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9238002"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9252329"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9267036"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346901"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9727751"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="34" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9238002"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9252329"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9267036"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9346901"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000305"/>
<sequence length="1424" mass="155293" checksum="732CDF0423161679" modified="1999-11-01" version="1">
MSGLGENLDPLASDSRKRKLPCDTPGQGLTCSGEKRRREQESKYIEELAELISANLSDID
NFNVKPDKCAILKETVRQIRQIKEQGKTISNDDDVQKADVSSTGQGVIDKDSLGPLLLQA
LDGFLFVVNRDGNIVFVSENVTQYLQYKQEDLVNTSVYNILHEEDRKDFLKNLPKSTVNG
VSWTNETQRQKSHTFNCRMLMKTPHDILEDINASPEMRQRYETMQCFALSQPRAMMEEGE
DLQSCMICVARRITTGERTFPSNPESFITRHDLSGKVVNIDTNSLRSSMRPGFEDIIRRC
IQRFFSLNDGQSWSQKRHYQEAYLNGHAETPVYRFSLADGTIVTAQTKSKLFRNPVTNDR
HGFVSTHFLQREQNGYRPNPNPVGQGIRPPMAGCNSSVGGMSMSPNQGLQMPSSRAYGLA
DPSTTGQMSGARYGGSSNIASLTPGPGMQSPSSYQNNNYGLNMSSPPHGSPGLAPNQQNI
MISPRNRGSPKIASHQFSPVAGVHSPMASSGNTGNHSFSSSSLSALQAISEGVGTSLLST
LSSPGPKLDNSPNMNITQPSKVSNQDSKSPLGFYCDQNPVESSMCQSNSRDHLSDKESKE
SSVEGAENQRGPLESKGHKKLLQLLTCSSDDRGHSSLTNSPLDSSCKESSVSVTSPSGVS
SSTSGGVSSTSNMHGSLLQEKHRILHKLLQNGNSPAEVAKITAEATGKDTSSITSCGDGN
VVKQEQLSPKKKENNALLRYLLDRDDPSDALSKELQPQVEGVDNKMSQCTSSTIPSSSQE
KDPKIKTETSEEGSGDLDNLDAILGDLTSSDFYNNSISSNGSHLGTKQQVFQGTNSLGLK
SSQSVQSIRPPYNRAVSLDSPVSVGSSPPVKNISAFPMLPKQPMLGGNPRMMDSQENYGS
SMGGPNRNVTVTQTPSSGDWGLPNSKAGRMEPMNSNSMGRPGGDYNTSLPRPALGGSIPT
LPLRSNSIPGARPVLQQQQQMLQMRPGEIPMGMGANPYGQAAASNQLGSWPDGMLSMEQV
SHGTQNRPLLRNSLDDLVGPPSNLEGQSDERALLDQLHTLLSNTDATGLEEIDRALGIPE
LVNQGQALEPKQDAFQGQEAAVMMDQKAGLYGQTYPAQGPPMQGGFHLQGQSPSFNSMMN
QMNQQGNFPLQGMHPRANIMRPRTNTPKQLRMQLQQRLQGQQFLNQSRQALELKMENPTA
GGAAVMRPMMQPQVSSQQGFLNAQMVAQRSRELLSHHFRQQRVAMMMQQQQQQQQQQQQQ
QQQQQQQQQQQQQQQQTQAFSPPPNVTASPSMDGLLAGPTMPQAPPQQFPYQPNYGMGQQ
PDPAFGRVSSPPNAMMSSRMGPSQNPMMQHPQAASIYQSSEMKGWPSGNLARNSSFSQQQ
FAHQGNPAVYSMVHMNGSSGHMGQMNMNPMPMSGMPMGPDQKYC
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>